LIMS1 and malignant colon neoplasm: Lastly, we assessed the impact of altered RBMS3 expression on LIMS1 mRNA stability in colon cancer cells treated with Actinomycin D, revealing that RBMS3 amplified the stability of LIMS1 mRNA (Figure 4G,H).